Enable Accessibility Enable Accessibility

Our Products

Hero_885

We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Our R&D efforts are focused on four key therapeutic areas: Gastroenterology (GI), Critical Illness, Rare Diseases and Neuroscience. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

 

Brand name

Generic name

Gastroenterology

Dexilant

Dexlansoprazole

Takepron

Lansoprazole

Pantoloc

Pantoprazole

Faktu

Policresulen/Cinchocaine

Entyvio

Vedolizumab

Mezavant

Mesalazine

Critical Illness

Adcetris

Brentuximab vedotin

Alunbrig

Brigatinib

Enantone

Leuprorelin acetate

Ninlaro

Ixazomib citrate

Rare Diseases

Advate

Octocog alfa Antihemophilic Factor (Recombinant)

Agrylin

Anagrelide

Feiba

Anti-inhibitor coagulant complex

Kiovig

Human Normal Immunoglobin (IVIg)

Neuroscience

Vyvanse

Lisdexamfetamine Dimesylate

Others

Fosrenol

Lanthanum Carbonate

Gutron

Midodrine

Ubretid

Distigmine

C-APROM/HK/CORP/0063 (01/2021)